Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone plus azathioprine for virus-negative myocarditis or inflammatory cardiomyopathy
2020-003877-23Phase 4Active
- Sponsor
- Medical University of Warsaw
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of azathioprine and prednisone in myocarditis and inflammatory cardiomyopathy (2 arms), sponsored by Medical University of Warsaw. Primary endpoint: Left ventricular ejection fraction at 12 months. Started Jan 2021; status: active.
02
Drugs
azathioprineprednisone
03
Conditions
myocarditisinflammatory cardiomyopathy
Beyond the preview
Go deeper on 2020-003877-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003877-23.